All regulations
Nonrulemaking
FDA
FDA-2025-N-3346
Elite Laboratories, Inc., et al.; Withdrawal of Approval of 72 Abbreviated New Drug Applications
Documents
2
Comments
0
Key Dates
Comment Period OpensMar 26, 2026
Documents
| Type | Title | Status |
|---|---|---|
Notice |
Keywords
2025-08
CDER
Elite Laboratories Inc et al Withdrawal of
Approval of 72 Abbreviated New Drug Applications
OPEN
Data from Regulations.gov